SCHEMBL136361

SCHEMBL136361

Cc1ccc(C=O)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.47
PRKDC P78527 1/20 0.45
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SRC P12931 1/20 0.43
ERN1 O75460 3/20 0.41
CYP2A6 P11509 1/20 0.41
NQO2 P16083 1/20 0.40
CYP1A2 P05177 1/20 0.39
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
MPI P34949 1/20 0.38
KMT2A Q03164 1/20 0.38
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29387108 1.00 ALDH1A1 (0.50) ALDH1A1KDM4EGAAPRKDCLMNA
SCHEMBL31540801 0.82 SRC (0.47) ALDH1A1KDM4EGAAPRKDCLMNA
SCHEMBL135760 0.82 SRC (0.47) ALDH1A1KDM4EGAAPRKDCLMNA
SCHEMBL2888296 0.78 ERN1 (0.52) ALDH1A1KDM4EGAALMNASMN1; SMN2
SCHEMBL2691345 0.78 CYP2A6 (0.48) ALDH1A1KDM4EGAAPRKDCLMNA
SCHEMBL18814757 0.77 ALDH1A1 (0.46) ALDH1A1KDM4EGAALMNASRC
SCHEMBL21240056 0.77 NQO2 (0.35) ALDH1A1KDM4EMAPTSMN1; SMN2HPGD
SCHEMBL2141046 0.77 TDP1 (0.40) ALDH1A1KDM4EMAPTSMN1; SMN2HPGD
SCHEMBL1162125 0.76 ERN1 (0.56) ALDH1A1PRKDCLMNAL3MBTL1ERN1
SCHEMBL29437223 0.76 ALDH1A1 (0.52) ALDH1A1KDM4EGAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120117974-A Synthetic method for preparing di-deuterated primary alcohol by catalytic aldehyde hydrogenation and hydrogen-deuterium exchange reaction 中国科学院大连化学物理研究所 2025-06-10 CN claimed
CN-118026796-A Synthetic method for decarbonylation deuteration reaction of rhodium-catalyzed aldehyde compound 中国科学院大连化学物理研究所 2024-05-14 CN claimed
CN-110372722-B Method for synthesizing sulfur-nitrogen-containing bis-heterocyclic compound 河南师范大学 2020-08-11 CN claimed
US-20260125346-A1 Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease BEONE MEDICINES I GMBH (CH) 2026-05-07 US disclosed
EP-4709711-A1 ISOQUINOLINONE DERIVATIVES AND 4H-QUINOLIZINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF DISEASE Beone Medicines I GmbH (CH) 2026-03-18 EP disclosed
EP-3565808-B1 COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS ARDELYX INC (US) 2026-03-04 EP disclosed
US-12565497-B2 Sulfone derivatives HOFFMANN-LA ROCHE INC. (US) 2026-03-03 US disclosed
EP-3573972-B1 RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2026-01-14 EP disclosed
US-12391695-B2 PRMT5 inhibitors LUPIN LIMITED (IN) 2025-08-19 US disclosed
US-20250250230-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-08-07 US disclosed
US-20250195483-A1 SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMA (US) 2025-06-19 US disclosed
CN-1933826-A Novel pharmaceutical compositions comprising agonists of the thyroid receptor KAROBIO AB (SE) 2007-03-21 CN disclosed
WO-2006136309-A1 CRIPOWELLINS AND SYNTHETIC DERIVATIVES THEREOF USED AS MEDICAMENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2006-12-28 WO disclosed
EP-1278746-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE Abbott Laboratories (US) 2003-01-29 EP disclosed
WO-2001083480-A2 DIHYDROPYRIDINE COMPOUNDS AND METHODS OF USE ABBOTT LABORATORIES (US) 2001-11-08 WO disclosed
EP-0691973-A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-01-17 EP disclosed
WO-1994022871-A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-10-13 WO disclosed
US-4847438-A INSECTICIDES NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1989-07-11 US disclosed
US-4668701-A Pesticides NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-05-26 US disclosed
EP-0104432-A2 Herbicide and plant growth regulator comprising alpha-beta-unsaturated compound TEIJIN LIMITED (JP) 1984-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250230-A1 HETEROCYCLIC COMPOUND HCRTR2, HCRTR1, NPY2R ALDH1A1 976/4885KDM4E 1217/4885GAA 2452/4885
US-12391695-B2 PRMT5 inhibitors PRMT5, PRMT1, PRMT3 ALDH1A1 3123/4885KDM4E 142/4885GAA 885/4885
US-20250195483-A1 SPIRO PIPERIDINE DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME APOL1, PNLIP, SAAL1 ALDH1A1 1983/4885KDM4E 4713/4885GAA 2342/4885
US-20260125346-A1 Isoquinolinone Derivatives and 4H-Quinolizinone Derivatives and Pharmaceutical Compositions Thereof for the Treatment of Disease NR3C1, NR3C2, PIK3R4 ALDH1A1 1598/4885KDM4E 3237/4885GAA 1003/4885
US-12565497-B2 Sulfone derivatives CXCR1, CCR1, SULT1E1 ALDH1A1 1332/4885KDM4E 3565/4885GAA 2525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.